Standout Papers
Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Metabonomic investigations in mice infected with Schistosoma mansoni : An approach for biomarker identification
2004
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns
2010 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Therapeutic effects of hepatocyte growth factor-overexpressing dental pulp stem cells on liver cirrhosis in a rat model
2017
Metal–organic framework-based materials: superior adsorbents for the capture of toxic and radioactive metal ions
2018 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
The DNA-damage response in human biology and disease
2009 StandoutNature
Estrogen and phytoestrogen regulate the mRNA expression of adrenomedullin and adrenomedullin receptor components in the rat uterus
2004
Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes
2005 StandoutNobel
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
2006 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
2006
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
2005
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Pharmacokinetics, Metabolism, and Carcinogenicity of Arsenic
2001
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer
2015
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Epigenetics in Cancer
2008 Standout
Angiotensin II (ATII)-inducible Platelet-derived Growth Factor A-chain Gene Expression Is p42/44 Extracellular Signal-regulated Kinase-1/2 and Egr-1-dependent and Mediated via the ATII Type 1 but Not Type 2 Receptor
1999
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Alkylation damage in DNA and RNA—repair mechanisms and medical significance
2004
New approaches to understanding p53 gene tumor mutation spectra
1999
Engineering hepatocellular morphogenesis and function via ligand‐presenting hydrogels with graded mechanical compliance
2004
DNA Damage, Aging, and Cancer
2009 Standout
Primary small cell carcinoma of esophagus: Report of 9 cases and review of literature
2004
Gut microorganisms, mammalian metabolism and personalized health care
2005
Revealing the human mucinome
2022 StandoutNobel
Cancer-associated mucins: role in immune modulation and metastasis
2019
Pathophysiological regulation of the AT1-receptor and implications for vascular disease
2006
Downregulation of theKlothoGene in the Kidney under Sustained Circulatory Stress in Rats
1998
Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats
2000
Clinicopathologic features and histochemical analyses of proliferative activity and angiogenesis in small cell carcinoma of the esophagus
2007 StandoutNobel
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Proceedings of a workshop on DNA adducts: Biological significance and applications to risk assessment Washington, DC, April 13–14, 2004
2005
Estrogen, natriuretic peptides and the renin–angiotensin system
1999
In Vivo klotho Gene Delivery Protects against Endothelial Dysfunction in Multiple Risk Factor Syndrome
2000
The Hallmarks of Aging
2013 Standout
Oral Exposure of Dimethylarsinic Acid, a Main Metabolite of Inorganic Arsenics, in Mice Leads to an Increase in 8-Oxo-2′-deoxyguanosine Level, Specifically in the Target Organs for Arsenic Carcinogenesis
2001
Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2
2004 StandoutNobel
Predictive factors for epidermal growth factor receptor inhibitors—The bull's-eye hits the arrow
2004
Lessons from rat models of hypertension from Goldblatt to genetic engineering
1998
Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy
2002
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Metal-induced oxidative stress and signal transduction
2004
Prediabetes: a high-risk state for diabetes development
2012 Standout
Defective arachidonate release and PGE2 production in Giα2-deficient intestinal and colonic subepithelial myofibroblasts
2006 StandoutNobel
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
2010
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects
2002
Histone lysine methylation and demethylation pathways in cancer
2010
Angiotensin II Induces Hypertrophy of Human Airway Smooth Muscle Cells: Expression of Transcription Factors and Transforming Growth Factor- β 1
1998
Role of Angiotensin II–Regulated Apoptosis Through Distinct AT 1 and AT 2 Receptors in Neointimal Formation
2002
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Angiotensin Blockade Inhibits Activation of Mitogen-Activated Protein Kinases in Rat Balloon-Injured Artery
1998 StandoutNobel
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Arsenite-induced formation of hydroxyl radical in the striatum of awake rats
2003
Contribution of Extracellular Signal-Regulated Kinase to Angiotensin II–Induced Transforming Growth Factor-β1 Expression in Vascular Smooth Muscle Cells
1999 StandoutNobel
Advanced Glycation End Products
2006 Standout
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension.
1998 StandoutNobel
Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension
1998 StandoutNobel
A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes
2003
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
2005 StandoutScience
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Arsenic: toxicity, oxidative stress and human disease
2011
Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice
2004
The Ecology of Arsenic
2003 StandoutScience
Inhibitory Regulation of Hypertrophy by Endogenous Atrial Natriuretic Peptide in Cultured Cardiac Myocytes
2000
Market Basket Survey Shows Elevated Levels of As in South Central U.S. Processed Rice Compared to California: Consequences for Human Dietary Exposure
2007
Surfing the p53 network
2000 StandoutNature
Transporters of arsenite in rice and their role in arsenic accumulation in rice grain
2008 Standout
Vascular targets for cannabinoids: animal and human studies
2013
Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3)
2011 StandoutNobel
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
2000
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
2008
Small-Cell Carcinomas of the Gastrointestinal Tract: A Review
2004
β-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration
2008 StandoutNobel
Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
2011
Neointimal Tissue Response at Sites of Coronary Stenting in Humans
1998
Works of Hideki Wanibuchi being referenced
Promotion of Rat Hepatocarcinogenesis by Dimethylarsinic Acid: Association with Elevated Ornithine Decarboxylase Activity and Formation of 8‐Hydroxydeoxyguanosine in the Liver
1997
Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas
2009
Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine
1999
Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats
1999
Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats
1996
Effects of Pioglitazone, a Peroxisome Proliferator–Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat
2009
Long-term survival after resection for small cell carcinoma of the esophagus
2001
Promotion of Skin Carcinogenesis by Dimethylarsinic Acid in Keratin (K6)/ODC Transgenic Mice
2000
Understanding arsenic carcinogenicity by the use of animal models
2004
A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response
2005
Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors
2002
Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21WAF1/Cip1, cyclin D1 and Ogg1
2002
Is the watanabe heritable hyperlipidemic rabbit a suitable experimental model for percutaneous transluminal coronary angioplasty in humans?
1993
Determination of trivalent methylated arsenicals in rat urine by liquid chromatography–inductively coupled plasma mass spectrometry after solvent extraction
2003
LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
1999
Dimethylarsinic acid induces 8-hydroxy-2′-deoxyguanosine formation in the kidney of NCI-Black-Reiter rats
2001
Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review
1997
JTE‐522, a selective cyclooxygenase‐2 inhibitor, inhibits induction but not growth and invasion of 1,2‐dimethylhydrazine‐induced tubular adenocarcinomas of colon in rats
2004
MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways
2013
Promotion by Sodium L‐Ascorbate in Rat Two‐stage Urinary Bladder Carcinogenesis is Dependent on the Interval of Administration
1999
Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine
2002
Possible rare involvement ofO6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models
1998
Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate
2000
Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.
2004
Characteristics of Diabetes, Blood Pressure, and Cardiac and Renal Complications in Otsuka Long-Evans Tokushima Fatty Rats
1997
Angiotensin II and calcium blockers prevent glomerular phenotypic changes in remnant kidney model.
1996
Urinary Sulfur-Containing Metabolite Produced by Intestinal Bacteria Following Oral Administration of Dimethylarsinic Acid to Rats
2003
Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats
2005
Contribution of Local Renin-Angiotensin System to Cardiac Hypertrophy, Phenotypic Modulation, and Remodeling in TGR(mRen2)27 Transgenic Rats
1996
Angiotensin II Type 1 Receptor Blockade Inhibits the Expression of Immediate-Early Genes and Fibronectin in Rat Injured Artery
1995
Role of CYP2E1 in Diethylnitrosamine-Induced Hepatocarcinogenesis In vivo
2007
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel